Related Experiment Video
Updated: Jun 6, 2025

Isolation of Lamina Propria Mononuclear Cells from Murine Colon Using Collagenase E
Published on: September 26, 2019
Immune Thrombocytopenic Purpura (ITP) With Ulcerative Colitis (UC)
Sohaib K Mohammed1, Sanjana Budamagunta2, Waleed A Khan3
1Internal Medicine, Countess of Chester Hospital NHS Foundation Trust, Chester, GBR.
Inflammatory bowel disease (IBD), including ulcerative colitis (UC), can present with immune thrombocytopenic purpura (ITP). This case highlights a unique presentation of ITP in a 70-year-old with UC.
Area of Science:
- Gastroenterology
- Immunology
- Hematology
Background:
- Inflammatory bowel disease (IBD) encompasses ulcerative colitis (UC) and Crohn's disease, characterized by chronic intestinal inflammation.
- UC can manifest with extra-intestinal complications, such as autoimmune cytopenias.
- Immune thrombocytopenic purpura (ITP) is a rare autoimmune disorder causing a significant decrease in platelet count.
Observation:
- Immune thrombocytopenic purpura (ITP) can be an extra-intestinal manifestation of ulcerative colitis (UC).
- The co-occurrence of ITP and UC is often observed at disease onset or during UC flare-ups.
- Diagnosis of ITP requires the exclusion of other potential causes for thrombocytopenia.
Findings:
- The severity of ITP has been noted to correlate with the extent of UC pathology.
- This report details a unique case of a 70-year-old patient experiencing ulcerative colitis (UC) concurrently with immune thrombocytopenic purpura (ITP).
Implications:
- Understanding the link between ITP and UC is crucial for comprehensive patient management.
- This case underscores the importance of considering ITP in UC patients presenting with unexplained thrombocytopenia.
- Further research may elucidate the immunopathogenic mechanisms linking ITP and UC.
More Related Videos
00:08Murine Appendectomy Model of Chronic Colitis Associated Colorectal Cancer by Precise Localization of Caecal Patch
Published on: August 24, 2019
08:58Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis
Published on: January 5, 2017
Related Concept Videos
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Drugs for Treatment of Ulcerative Colitis in IBD
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents